Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
CUBIST PHARMACEUTICALS INC
| Metric | CUBIST PHARMACEUTICALS INC Healthcare |
|---|---|
| Quality Score | 82 / 100 |
| Revenue (latest) | $230M |
| Net income (latest) | — |
| Operating margin | 11.5% |
| Net margin | — |
| Return on equity | — |
| Return on assets | — |
| Return on capital (ROCE) | 0.9% |
| Debt / equity | 1.26× |
| Revenue growth (YoY) | 8.6% |
| Altman Z″ (distress) | 2.09 |
| Accruals / assets | — |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.